People

Harry Dietz

Harry Dietz is a GSK independent non-executive director and scientific and medical expert appointed in January 2022. A physician-scientist specializing in human genetics and heritable connective-tissue disorders, he is known for research on Marfan syndrome and disease-modifying approaches in fibrosis and neurodegeneration.